Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Dec;37(1):1120-1195.
doi: 10.1080/14756366.2022.2061966.

Paving the way towards effective plant-based inhibitors of hyaluronidase and tyrosinase: a critical review on a structure-activity relationship

Affiliations
Review

Paving the way towards effective plant-based inhibitors of hyaluronidase and tyrosinase: a critical review on a structure-activity relationship

Jakub Gębalski et al. J Enzyme Inhib Med Chem. 2022 Dec.

Abstract

Human has used plants to treat many civilisation diseases for thousands of years. Examples include reserpine (hypertension therapy), digoxin (myocardial diseases), vinblastine and vincristine (cancers), and opioids (palliative treatment). Plants are a rich source of natural metabolites with multiple biological activities, and the use of modern approaches and tools allowed finally for more effective bioprospecting. The new phytochemicals are hyaluronidase (Hyal) inhibitors, which could serve as anti-cancer drugs, male contraceptives, and an antidote against venoms. In turn, tyrosinase inhibitors can be used in cosmetics/pharmaceuticals as whitening agents and to treat skin pigmentation disorders. However, the activity of these inhibitors is stricte dependent on their structure and the presence of the chemical groups, e.g. carbonyl or hydroxyl. This review aims to provide comprehensive and in-depth evidence related to the anti-tyrosinase and anti-Hyal activity of phytochemicals as well as confirming their efficiency and future perspectives.

Keywords: Hyaluronidase; polyphenols; structure–activity relationship; tyrosinase plant-based inhibitors.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this article.

Figures

None
Graphical abstract
Figure 1.
Figure 1.
Classification of hyaluronidases (HMWHA: long-chain hyaluronic acid; LMWHA: short-chain hyaluronic acid).
Figure 2.
Figure 2.
Chemical groups of flavonoids involved in the inhibition of hyaluronidase.
Figure 3.
Figure 3.
Effect of alkyl chain length in phenolic acids on activity against hyaluronidase.
Figure 4.
Figure 4.
Potential groups engaged in an interaction oligomers phenolic acids-hyaluronidase.
Figure 5.
Figure 5.
Potential groups engaged in an interaction fukiic acid derivative-hyaluronidase.
Figure 6.
Figure 6.
Chemical classification of tannins.
Figure 7.
Figure 7.
Structure of benzylisoquinoline alkaloids and apomorphine alkaloids.
Figure 8.
Figure 8.
Chemical groups of L-ascorbic acid involved in the inhibition of hyaluronidase.
Figure 9.
Figure 9.
Chemical structures of saponins. A – triterpene saponins, B – steroid saponins, C – steroid alkaloids, and D – isoprene.
Figure 10.
Figure 10.
Chemical groups of triterpenic acids involved in the inhibition of hyaluronidase.
Figure 11.
Figure 11.
3-O-β-D-glucuronopyranoside group.
Figure 12.
Figure 12.
A – reaction hydroxylation of monophenols to o-diphenols; reaction B – oxidation of o-diphenols to o-quinones.
Figure 13.
Figure 13.
Mechanism of the tyrosinase action as monophenolase and diphenolase.
Figure 14.
Figure 14.
The pathway of melanin synthesis.
Figure 15.
Figure 15.
a) Potential groups engaged in an interaction hydroxybenzoic acid-tyrosinase and b) Potential groups engaged in an interaction hydroxycinnamic acid-tyrosinase.
Figure 16.
Figure 16.
Potential groups engaged in an interaction flavonoid-tyrosinase.
Figure 17.
Figure 17.
Structure relationship between flavanol (a) and kojic acid (b) and mode of copper chelation by 3-hydroxy-4-keto group in flavanol (c), and kojic acid (d).
Figure 18.
Figure 18.
Chemical classification of lignans.
Figure 19.
Figure 19.
Chemical structure of cis- and trans-isomer of stilbenes.
Figure 20.
Figure 20.
Potential groups engaged in an interaction stilbene-tyrosinase.
Figure 21.
Figure 21.
a) A basic structure of chalcones (1,3-diphenyl-2-propen-1-one); b) The difference in structure between stilbenes and chalcones.
Figure 22.
Figure 22.
a) Similarity in the structure of L-tyrosine and 4-hydroxychalcones; b) Similarity in structure of L-DOPA and flavonol.
Figure 23.
Figure 23.
Potential groups engaged in an interaction chalcone-tyrosinase.
Figure 24.
Figure 24.
Structure of Phenlpropanoid Sucrose Esters – PSEs (R: phenylpropanoid residues).
Figure 25.
Figure 25.
Structure of α-piron (a); benzo-α-piron (b).
Figure 26.
Figure 26.
Potential groups engaged in an interaction coumarin-tyrosinase.

References

    1. Stafford A, Morris P, Fowler MW.. Plant cell biotechnology: a perspective. Enzyme Microb Technol 1986;8:578–87.
    1. Veeresham C. Natural products derived from plants as a source of drugs. J Adv Pharm Technol Res 2012;3:200–1. - PMC - PubMed
    1. Shakya AK. Medicinal plants: future source of new drugs. Int J Herb Med 2016;4:59–64.
    1. Stranska I, Skalicky M, Novak J, et al. . Analysis of selected poppy (Papaver somniferum L.) cultivars: pharmaceutically important alkaloids. Ind Crop Prod 2013;41:120–6.
    1. Li Y, Gao Z, Piao C, et al. . A stable and efficient Agrobacterium tumefaciens-mediated genetic transformation of the medicinal plant Digitalis purpurea L. Appl Biochem Biotechnol 2014;172:1807–17. - PubMed

LinkOut - more resources